menu
    • menu
    [{"orgOrder":0,"company":"HbO2 Therapeutics LLC","sponsor":"HbO2 Therapeutics LLC","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"INDONESIA","productType":"Peptide, Unconjugated","year":"2013","type":"Inapplicable","leadProduct":"HBOC-201","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"HbO2 Therapeutics LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Solution","sponsorNew":"HbO2 Therapeutics LLC \/ HbO2 Therapeutics LLC","highestDevelopmentStatusID":"1","companyTruncated":"HbO2 Therapeutics LLC \/ HbO2 Therapeutics LLC"},{"orgOrder":0,"company":"HbO2 Therapeutics LLC","sponsor":"HbO2 Therapeutics LLC","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"U.S.A","productType":"Peptide, Unconjugated","year":"2016","type":"Inapplicable","leadProduct":"HBOC-201","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"HbO2 Therapeutics LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"HbO2 Therapeutics LLC \/ HbO2 Therapeutics LLC","highestDevelopmentStatusID":"1","companyTruncated":"HbO2 Therapeutics LLC \/ HbO2 Therapeutics LLC"},{"orgOrder":0,"company":"HbO2 Therapeutics LLC","sponsor":"HbO2 Therapeutics LLC","pharmaFlowCategory":"DU","therapeuticArea":"Hematology","country":"","productType":"Peptide, Unconjugated","year":"2018","type":"Inapplicable","leadProduct":"HBOC-201","moa":"Undisclosed","graph1":"Hematology","graph2":"Undisclosed","graph3":"HbO2 Therapeutics LLC","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Hematology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"HbO2 Therapeutics LLC \/ HbO2 Therapeutics LLC","highestDevelopmentStatusID":"1","companyTruncated":"HbO2 Therapeutics LLC \/ HbO2 Therapeutics LLC"}]

    Find Clinical Drug Pipeline Developments & Deals by HbO2 Therapeutics LLC

    Menu

    HbO2 Therapeutics LLC

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            HbO2 Therapeutics LLC

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed

                            HbO2 Therapeutics LLC

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HBOC-201

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Recipient : Jonathan H. Waters

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

                            Details : HBOC-201 is a Peptide drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            August 16, 2018

                            Lead Product(s) : HBOC-201

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Recipient : Jonathan H. Waters

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            HbO2 Therapeutics LLC

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed

                            HbO2 Therapeutics LLC

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HBOC-201

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Recipient : Johns Hopkins University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Expanded Access Protocol Using HBOC-201

                            Details : HBOC-201 is a Peptide drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            February 18, 2016

                            Lead Product(s) : HBOC-201

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Recipient : Johns Hopkins University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            HbO2 Therapeutics LLC

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed

                            HbO2 Therapeutics LLC

                            U.S.A arrow
                            Biotech Showcase
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : HBOC-201

                            Therapeutic Area : Hematology

                            Study Phase : Undisclosed

                            Recipient : Gadjah Mada University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

                            Details : HBOC-201 is a Peptide drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia.

                            Product Name : Undisclosed

                            Product Type : Peptide, Unconjugated

                            Upfront Cash : Inapplicable

                            June 19, 2013

                            Lead Product(s) : HBOC-201

                            Therapeutic Area : Hematology

                            Highest Development Status : Undisclosed

                            Recipient : Gadjah Mada University

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.